Owners of midsize nursing home chains drain billions from facilities, hiding behind opaque accounting practices and harming the elderly as government,...
At a time when biotech is still counting its losses as a thaw gradually sets in after the long market winter, pharma has been on a...
The crisis in NHS dentistry is driving increasing numbers abroad for treatment. Here are some of their stories.
Ramiro Ribeiro After six years as head of clinical development at Apellis Pharmaceuticals, Ramiro Ribeiro is joining EyePoint Pharmaceuticals as CMO. “The...
To build or to buy? That’s a classic question for pharma boardrooms, and Novo Nordisk is going with both. Beyond spending billions of dollars to expand...
Ivan Cheung Ivan Cheung, who led Eisai’s US business and was a central figure in the biotech’s Alzheimer’s work, has stepped into the CEO position...
Some are saying that mRNA medicines—mRNA vaccines and mRNA therapeutics alike—will open a golden era of medicine. And the enthusiasm is catching. Following...
The convergence of polymer chemistry, materials science, biology, and computation lets scientists assess a plethora of polymer delivery options. The post...
Northwestern University researchers have successfully coaxed a deadly pathogen to destroy itself from the inside out. Credit: Cole Wilson/Northwestern...
Stock investors searching for holistic exposure to psychedelic medicine should add Numinus Wellness to their due diligence lists. The post Numinus Wellness...
Smell training is one of the few options for recovering a lost sense of smell – but can we make it more effective?
FRANKFURT. Each year, several thousand women in Germany die from ovarian cancer. In many cases, the disease is only detected when it is very advanced and...
If you’re in neuroscience, you’ve probably heard of him. Few people have dipped a hand in as many neuroscience biotechs and government research units...
Blank check companies are largely dead and gone, but Bihua Chen and her life sciences investment firm Cormorant are back with a second special purpose...
Blank check companies are largely dead and gone, but Bihua Chen and her life sciences investment firm Cormorant are back with a second special purpose...
“In the future, targeting of RBMX may be a novel method in cancer therapy.” Credit: 2024 Sheng et al. “In the future, targeting of RBMX may...
St. Jude Children’s Research Hospital announces today that St. Jude Home Care LLC, a home health agency for the hospital’s patients, earned dual certifications...
Illumina observes that fields benefiting from low-cost sequencing include oncology, virology, and agricultural biotechnology. The post Inexpensive Sequencing...
Precedence Research reports that the global cell and gene therapy market size was about $15.54 billion in 2022 and is projected to reach approximately...
The Propaganda That Is Selective Science Authored by Lori Weintz via The Brownstone Institute, I am calling for a halt of the use of mRNA...
2024: The Year Of Deepening Social Tensions - Anecdotal Evidence Of Three Worldviews Authored by Ronni Stoeferle via GoldSwitzerland.com, In...
Combined market cap falls 2% year over year, with 16 of the largest public companies losing value and just 5 outperforming the S&P 500. The post...
The archival trove chronicles the extreme measures administrators took to ensure Black sharecroppers did not receive treatment for the venereal diseas...
The archival trove chronicles the extreme measures administrators took to ensure Black sharecroppers did not receive treatment for the venereal diseas...
When pathogens attack the body, the innate immune system goes to work protecting against the invading disease. The innate immune system is the first line...
AI-designed drugs have been entering the early phases of clinical trials over the past couple of years. GEN recently interviewed experts from four pioneering...
“Understanding the influence of prior treatments on CH [clonal hematopoiesis] dynamics is crucial for comprehending the intricate interplay between therapy,...
Sexual assault referral centres help thousands of survivors.
The COVID-19 pandemic demonstrated the promise of using mRNA as medicine. But before mRNA drugs can go beyond vaccines, researchers need to identify the...
The COVID-19 pandemic demonstrated the promise of using mRNA as medicine. But before mRNA drugs can go beyond vaccines, researchers need to identify the...